Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast Cancer

PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

2,000

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

May 31, 2006

Study Completion Date

December 31, 2025

Conditions

Breast Cancer

Interventions

BIOLOGICAL

pegfilgrastim

DRUG

cyclophosphamide

DRUG

epirubicin hydrochloride

DRUG

fluorouracil

DRUG

paclitaxel

PROCEDURE

adjuvant therapy

All Listed Sponsors

collaborator

Gruppo Italiano Mammella (GIM)

OTHER

lead

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy

OTHER